Review ArticleManaging hypertension in patients with chronic kidney diseaseZuber, Kim PA-C, DFAAPA; Gilmartin, Cheryl PharmD; Davis, Jane DNP Author Information Kim Zuber practices at Metropolitan Nephrology in Alexandria, Va., and is CME chair of the National Kidney Foundation. Cheryl Gilmartin is a clinical assistant professor in the departments of pharmacy practice and nephrology at the University of Illinois Hospital and Health Sciences System in Chicago, Ill. Jane S. Davis is a nurse practitioner at the University of Alabama at Birmingham and a member of the National Kidney Foundation board. The authors have disclosed no potential conflicts of interest, financial or otherwise. Acknowledgment: The authors would like to thank Van Nguyen and Lauren Rothrock, PharmD students at the University of Illinois Hospital and Health Sciences System, for their assistance with this manuscript. JAAPA: September 2014 - Volume 27 - Issue 9 - p 37-46 doi: 10.1097/01.JAA.0000453239.92473.41 Buy Metrics Abstract Chronic kidney disease (CKD) and hypertension are intrinsically linked. Although 59% of the US population will be diagnosed with CKD during their lifetimes, mortality is usually due to a cardiovascular event. Sodium restriction and a combination of a renin-angiotensin-aldosterone medication and a calcium channel blocker are the most effective methods of managing hypertension in patients with CKD. © 2014 American Academy of Physician Assistants.